Dr. Prih Rohra is an Assistant Professor of Pathology at the University of Texas Medical Branch (UTMB), with specialized expertise in Genitourinary Pathology and Cytopathology. She completed advanced fellowship training in Surgical Pathology, Cytopathology, and Genitourinary Pathology at the University of Texas MD Anderson Cancer Center, one of the most prestigious training environments for oncologic pathology. Her multidisciplinary training provides her with a comprehensive diagnostic perspective that spans both histopathology and cytologic evaluation.
A dedicated and forward-thinking researcher, Dr. Rohra has developed a strong investigative focus on renal neoplasia, particularly in the context of emerging diagnostic technologies. She is currently part of a collaborative research group studying the integration of artificial intelligence (AI) into the classification and prognostic assessment of renal tumors, an area poised to reshape diagnostic pathology. Her earlier work includes important contributions to refining the grossing protocols and reporting guidelines for post-immunotherapy renal tumors, an increasingly encountered diagnostic challenge as immunotherapeutic agents become more widely used in oncology.
Beyond renal pathology, Dr. Rohra has pursued impactful research in cytopathology. She has examined the utility of TRPS1 immunostaining on cytologic specimens, helping clarify its diagnostic role in breast pathology, and has also published on the performance and clinical integration of Afirma molecular testing in thyroid cytology, contributing to improved risk stratification and patient management.
Dr. Rohra’s body of work reflects a thoughtful blend of diagnostic expertise, methodological rigor, and innovation. Her ongoing research has the potential to meaningfully advance the practice of pathology, particularly in areas where technology, morphology, and molecular diagnostics intersect, ultimately improving diagnostic accuracy and patient outcomes.